Literature DB >> 33494724

Preoperative thyroid hormone levels predict ICU mortality after cardiopulmonary bypass in congenital heart disease patients younger than 3 months old.

Di Yu1, Liang Zou1, Yueshuang Cun1, Yaping Li1, Qingfeng Wang1, Yaqin Shu2, Xuming Mo3.   

Abstract

BACKGROUND: We aimed to study the effectiveness of preoperative thyroid hormone levels in predicting intensive care unit (ICU) mortality after cardiopulmonary bypass (CPB) in infants with congenital heart disease (CHD).
METHODS: We retrospectively reviewed and analyzed data from 133 patients younger than 3 months old who underwent cardiac surgery with CPB from June 2017 to November 2019. ICU mortality prediction was assessed by multivariate binary logistic regression analysis and area under the curve (AUC) analysis.
RESULTS: Non-survivors were younger (17.46 ± 17.10 days vs. 38.63 ± 26.87 days, P = 0.006), with a higher proportion of neonates (9/13 vs. 41/120, P = 0.017) and a higher proportion of individuals with a Risk Adjustment for Congenital Heart Surgery-1 (RACHS-1) score ≥ 4 (8/13 vs. 31/120, P = 0.020). No significant difference was found in CPB and aortic cross-clamping (ACC) time. The levels of free triiodothyronine (FT3) (3.91 ± 0.99 pmol/L vs. 5.11 ± 1.55 pmol/L, P = 0.007) and total triiodothyronine (TT3) (1.55 ± 0.35 nmol/L vs. 1.90 ± 0.57 nmol/L, P = 0.032) were higher in survivors than in non-survivors. In the ICU mortality prediction assessment, FT3 was an independent mortality predictor and showed a high AUC (0.856 ± 0.040).
CONCLUSIONS: The preoperative FT3 level was a powerful and independent predictor of ICU mortality after CPB in infants with CHD younger than 3 months old.

Entities:  

Keywords:  Congenital heart disease; Mortality; Thyroid hormone

Year:  2021        PMID: 33494724      PMCID: PMC7831186          DOI: 10.1186/s12887-021-02513-6

Source DB:  PubMed          Journal:  BMC Pediatr        ISSN: 1471-2431            Impact factor:   2.125


  33 in total

1.  Thyroid dysfunction after pediatric cardiac surgery.

Authors:  Brian A Lynch; David M Brown; Cynthia Herrington; Elizabeth Braunlin
Journal:  J Thorac Cardiovasc Surg       Date:  2004-05       Impact factor: 5.209

2.  Oral Triiodothyronine for Infants and Children Undergoing Cardiopulmonary Bypass.

Authors:  Eva M Marwali; Cindy E Boom; Novik Budiwardhana; Dicky Fakhri; Poppy S Roebiono; Anwar Santoso; Sudigdo Sastroasmoro; April Slee; Michael A Portman
Journal:  Ann Thorac Surg       Date:  2017-02-06       Impact factor: 4.330

Review 3.  Consensus-based method for risk adjustment for surgery for congenital heart disease.

Authors:  Kathy J Jenkins; Kimberlee Gauvreau; Jane W Newburger; Thomas L Spray; James H Moller; Lisa I Iezzoni
Journal:  J Thorac Cardiovasc Surg       Date:  2002-01       Impact factor: 5.209

4.  Thyroid and brain natriuretic Peptide response in children undergoing cardiac surgery for congenital heart disease- age-related variations and prognostic value.

Authors:  Massimiliano Cantinotti; Valentina Lorenzoni; Simona Storti; Riccardo Moschetti; Bruno Murzi; Marco Marotta; Maura Crocetti; Sabrina Molinaro; Aldo Clerico; Michael Portman; Giorgio Iervasi
Journal:  Circ J       Date:  2012-09-27       Impact factor: 2.993

5.  Oral Triiodothyronine Supplementation Decreases Low Cardiac Output Syndrome After Pediatric Cardiac Surgery.

Authors:  Eva M Marwali; Putri Caesa; Sekarpramita Darmaputri; Alvin A Sani; Poppy S Roebiono; Dicky Fakhri; Mulyadi M Djer; Zakiudin M Munasir; Jose R L Batubara; Sudigdo Satroasmoro; Michael A Portman; Nikolaus A Haas
Journal:  Pediatr Cardiol       Date:  2019-07-15       Impact factor: 1.655

6.  Risk stratification models for congenital heart surgery in children: Comparative single-center study.

Authors:  Sara Bobillo-Perez; Joan Sanchez-de-Toledo; Susana Segura; Monica Girona-Alarcon; Maria Mele; Anna Sole-Ribalta; Debora Cañizo Vazquez; Iolanda Jordan; Francisco Jose Cambra
Journal:  Congenit Heart Dis       Date:  2019-09-23       Impact factor: 2.007

Review 7.  Thyroid hormone supplementation for the prevention of morbidity and mortality in infants undergoing cardiac surgery.

Authors:  S Dimmick; N Badawi; T Randell
Journal:  Cochrane Database Syst Rev       Date:  2004

8.  [Thyroid function profile in infants submitted to cardiac surgery with cardiopulmonary bypass.].

Authors:  Paula Maria da Cruz; Carmem Narvaes Bello; Miguel Lorenzo Barbero Marcial; José Otávio Costa Auler Júnior
Journal:  Rev Bras Anestesiol       Date:  2004-06       Impact factor: 0.964

9.  RACHS-1 score as predictive factor for postoperative ventilation time in children with congenital heart disease.

Authors:  Luisa Geier; Christoph Menzel; Ingo Germund; Uwe Trieschmann
Journal:  Cardiol Young       Date:  2020-01-17       Impact factor: 1.093

10.  Low triiodothyronine predicts mortality in critically ill patients.

Authors:  K V S Hari Kumar; Umesh Kapoor; Richa Kalia; N S Ajai Chandra; Parikshit Singh; R Nangia
Journal:  Indian J Endocrinol Metab       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.